↓ Skip to main content

Pharmacological Mechanisms in Alzheimer's Therapeutics

Overview of attention for book
Cover of 'Pharmacological Mechanisms in Alzheimer's Therapeutics'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Overview of the Alzheimer's Disease Pathology and Potential Therapeutic Targets
  3. Altmetric Badge
    Chapter 2 Trial Designs and Outcomes to Monitor Novel Therapeutics in Alzheimer's Disease
  4. Altmetric Badge
    Chapter 3 The Pharmacological Treatment of Alzheimer's Disease with Cholinesterase Inhibitors and Memantine
  5. Altmetric Badge
    Chapter 4 M1 Muscarinic Agonists: A Comprehensive Therapy Against Major Hallmarks of Alzheimer's Disease
  6. Altmetric Badge
    Chapter 5 Cholinergic Neurodegeneration in Alzheimer's Disease: Basis for Nerve Growth Factor Therapy
  7. Altmetric Badge
    Chapter 6 The Rationale for Glutamatergic Therapy in Alzheimer's Disease
  8. Altmetric Badge
    Chapter 7 Secretases as Pharmacological Targets in Alzheimer's Disease
  9. Altmetric Badge
    Chapter 8 γ-Secretase as a Target for Alzheimer's Disease
  10. Altmetric Badge
    Chapter 9 The Rationale for an Immunological Approach to Alzheimer's Therapeutics
  11. Altmetric Badge
    Chapter 10 Neuroinflammation, Alzheimer Disease, and Other Aging Disorders
  12. Altmetric Badge
    Chapter 11 Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and Derived Aβ42-Lowering Molecules for Treatment and Prevention of Alzheimer's Disease (AD)
  13. Altmetric Badge
    Chapter 12 The Potential Application of Antioxidant Agents in Alzheimer Disease Therapeutics
  14. Altmetric Badge
    Chapter 13 Apolipoprotein E: A Potent Gene-Based Therapeutic Target for the Treatment of Sporadic Alzheimer's Disease
  15. Altmetric Badge
    Chapter 14 Tau Pathology as a Target in Alzheimer's Therapeutics
  16. Altmetric Badge
    Chapter 15 Design of Inhibitors of Amyloid-β Misfolding and Aggregation for Alzheimer's Therapy
  17. Altmetric Badge
    Chapter 16 Potential Applications of Glycosaminoglycan-Related Compounds in Alzheimer's Disease
  18. Altmetric Badge
    Chapter 17 Multifunctional Neuroprotective Drugs for the Treatment of Alzheimer's Disease
  19. Altmetric Badge
    Chapter 18 Interpreting Clinical Studies of Putative Therapeutics for Alzheimer's Disease: The Case of Statins and NSAIDs
Overall attention for this book and its chapters
Altmetric Badge

Mentioned by

blogs
1 blog

Readers on

mendeley
35 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pharmacological Mechanisms in Alzheimer's Therapeutics
Published by
Springer New York, October 2007
DOI 10.1007/978-0-387-71522-3
ISBNs
978-0-387-71521-6, 978-0-387-71522-3, 978-1-4419-2446-9
Authors

A. Claudio Cuello, Cuello, A. Claudio

Editors

Cuello, A. Claudio

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Poland 1 3%
Brazil 1 3%
Unknown 33 94%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 20%
Researcher 6 17%
Student > Bachelor 6 17%
Student > Master 6 17%
Other 3 9%
Other 5 14%
Unknown 2 6%
Readers by discipline Count As %
Chemistry 7 20%
Agricultural and Biological Sciences 6 17%
Biochemistry, Genetics and Molecular Biology 5 14%
Psychology 3 9%
Neuroscience 3 9%
Other 6 17%
Unknown 5 14%